SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-014257
Filing Date
2023-05-12
Accepted
2023-05-12 16:33:00
Documents
49
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ctdh20230331_10q.htm   iXBRL 10-Q 520707
2 EXHIBIT 31.1 ex_515018.htm EX-31.1 13507
3 EXHIBIT 31.2 ex_515019.htm EX-31.2 13383
4 EXHIBIT 32.1 ex_515020.htm EX-32.1 5072
5 EXHIBIT 32.2 ex_515021.htm EX-32.2 5464
  Complete submission text file 0001437749-23-014257.txt   3460370

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20230331.xsd EX-101.SCH 38076
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctdh-20230331_cal.xml EX-101.CAL 28157
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20230331_def.xml EX-101.DEF 291721
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20230331_lab.xml EX-101.LAB 237549
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20230331_pre.xml EX-101.PRE 301640
43 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20230331_10q_htm.xml XML 332680
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39780 | Film No.: 23916401
SIC: 2836 Biological Products, (No Diagnostic Substances)